1. Introduction {#sec1}
===============

Nucleotides are low molecular weight biological compounds that play important roles in essential physiological and biochemical functions ([@bib8]). Nucleotides are synthesized *de novo* in most tissues, but some immune and intestinal cells lack this process and depend on exogenous supply ([@bib23]). Hence, administration of exogenous nucleotides guarantees increased availability to the body at the time of high demand for various physiological activities ([@bib34]). Nucleotide supplementation has been one important aspect of research on clinical nutrition and functional food development for humans ([@bib15]), and the requirement for nucleotides in infants has been well accepted ([@bib7]).

Research into potential growth and health benefits of dietary nucleotides in aquaculture species began in early1990׳s ([@bib24], [@bib25]), and most of the further studies on nucleotide supplementation for fish started after the reports of [@bib5], [@bib6]. Till now, dietary supplementation of nucleotides has been tested in different aquatic species, and various beneficial effects of dietary nucleotides on fish have been reported, including improved growth, enhanced immune response ([@bib5], [@bib6], [@bib14], [@bib16]), increased tolerance to stresses ([@bib5], [@bib6], [@bib14], [@bib17], [@bib29], [@bib35], [@bib33], [@bib13]), and improved intestinal morphology ([@bib3], [@bib10], [@bib22]). Dietary nucleotide supplementation has been reported to improve the balance of infant intestinal microbiota ([@bib28], [@bib30]). The effect of nucleotide supplementation of infant formula on intestinal microbiota was proposed as potential mediator of the benefits of nucleotides supplementation for immune function, as neonatal gut microbiotas have long-term effects on immunity ([@bib28]). In addition, dose-response effects of dietary nucleotides inclusion were investigated in a few studies ([@bib13], [@bib17], [@bib29], [@bib35]), and doses of nucleotides products at 0.5 g/kg ([@bib35]), 1.5 g/kg ([@bib17]), 2 g/kg ([@bib29]) and 8 g/kg ([@bib13]) were registered as optimal for growth or immunity. Therefore, the optimal dosage of nucleotide addition was necessary to study depend on fish species. In addition, the influence of intestinal microbiota by dietary nucleotides in fish species has never been studied.

Hybrid tilapia (*Oreochromis niloticus ♀* × *Oreochromis aureus* ♂) are cultured worldwide for its fast growth rate, easy adaptation to different aquaculture conditions, and tender flesh ([@bib38]). Effects of nucleotides supplementation on tilapia were studied earlier; improved growth and specific immune responses to vaccination were reported ([@bib24], [@bib25]). However, only one or two 'recommended' inclusion doses were tested in these studies. The potential dose-response effect of nucleotide supplementation on growth and immune response, as well as the optimal supplementation rate, which have been investigated in other aquatic species, have never been studied in hybrid tilapia. Also, the influence of dietary nucleotide supplementation on non-specific immune responses, which is more directly relevant to regular disease resistance of fish, was not tested for hybrid tilapia in the above-mentioned studies. In this research, a series of nucleotides supplementation rates were incorporated to detect the dose effect of dietary nucleotides on growth and non-specific immune responses of hybrid tilapia. The impact of nucleotide supplementation on intestine growth and intestinal microbiota of hybrid tilapia was also investigated, as an initial trial to uncover the associated mechanisms of the beneficial effects of nucleotide supplementation on fish.

2. Materials and methods {#sec2}
========================

2.1. Animals and feeding {#sec2.1}
------------------------

All animal research was approved by the animal ethics committee of Feed Research Institute, Chinese Academy of Agricultural Sciences (permit number 2012-ZZG-ZF-001). Three hundred hybrid tilapias (*O. niloticus ♀* × *O. aureus* ♂) were obtained from a commercial aquaculture farm in Jiangmen City, Guangdong province, China. After disinfection with 2‰ salt solution within 30 min, the fish were acclimatized to the laboratory condition and fed the basal experimental diet without exogenous nucleotides for 2 weeks. After acclimation, fish with an average weight of approximately 8 g were randomly distributed into fifteen tanks (60 × 60 × 65 cm, 3 tanks per treatment and 20 fish per tank). The aquaria were supplied with recirculated de-chlorinated water at a rate of 0.5 L/min. During the feeding trial, the dissolved oxygen concentrations in the aquaria were higher than 6.0 mg O/L, and total nitrate/nitrite (${\text{NO}_{3}}^{-}$, ${\text{NO}_{2}}^{-}$) levels were less than 0.092 mg N/L with water temperature between 25.2 and 28.5°C. Aquaria were illuminated from 0800 to 2100 h every day.

The basal dietary formulation and proximate composition are given in [Table 1](#tbl1){ref-type="table"} ([@bib9]). The experimental diet was supplemented with a *Saccharomyces cerevisiae*-originated nucleotide mixture from Biotogether (Nanjing, China) at the dosage of (0, 0.15, 0.30, 0.60, and 1.20 g/100 g diet). The nucleotide mixture contained 49% nucleotides (12 ± 1% of 5′-AMP, 10 ± 1% of 5′-CMP, 16 ± 1% of 5′-GMP·Na~2~, and 11 ± 1% of 5′-UMP·Na~2~), 35% oligonucleotides, and 10% water, with the remainder comprised of proteins and polysaccharides. Dry and powdered ingredients were thoroughly mixed with water to make soft dough and then processed into 3 mm-diameter pellets. The pellets were dried in a hot air oven at 60°C until their moisture content was reduced to less than 10%. The dried pellets were then stored at 4°C until use. During the 8-week feeding trial, fish were hand-fed to apparent satiation twice daily (0900 and 1500).Table 1Feed formulation and proximate composition of test diets used in the experiment.[1](#tbl1fn1){ref-type="table-fn"}ItemControl0.15% nucleotides0.30% nucleotides0.60% nucleotides1.20% nucleotides**Ingredients, % DM**White fishmeal14.0014.0014.0014.0014.00Fly maggot meal6.006.006.006.006.00Soybean meal30.0030.0030.0030.0030.00Wheat42.0042.0042.0042.0042.00Vitamin C0.100.100.100.100.10Vitamin premix[2](#tbl1fn2){ref-type="table-fn"}0.100.100.100.100.10Mineral premix[3](#tbl1fn3){ref-type="table-fn"}0.500.500.500.500.50Choline chloride0.200.200.200.200.20α- starch (%)2.852.852.852.852.85Zeolite powder4.254.103.953.653.05Yeast-originated NT00.150.300.601.20**Chemical composition, % DM**Dry matter92.192.192.192.192.1Crude protein31.231.231.231.231.2Crude lipid4.74.74.74.74.7Ash6.56.46.25.95.3Gross energy, MJ/100 g1.721.721.721.721.72[^2][^3][^4]

2.2. Growth measurements and sampling {#sec2.2}
-------------------------------------

The fish in the experimental groups were pooled in a tank to weigh prior to the initial feeding. After the feeding trial was finished, tilapia were fasted for 24 h and weighed by tank. To determine feed stability in water, a known amount of feed was placed into a tank filled with water. The feed residue was collected 1 h later, dried at 70 °C and weighed. For calculation of the feeding rate and feed usage efficiency, any residual feed in the aquarium was collected one hour after feeding and then dried at 70°C. The measured weight of residue feed was adjusted by dissolving rate of feed to calculate the final feed residue weight. Weight gain (WG), feeding rate (FR) and feed efficiency (FE) were calculated as follows:$$\qquad{\text{WG}\left( \% \right) = 100 \times \left( \left. \text{fish}\mspace{9mu}\text{final}\mspace{9mu}\text{weight} - \text{fish}\mspace{9mu}\text{initial}\mspace{9mu}\text{weight} \right)/\qquad{\text{fish}\mspace{9mu}\text{initial}\mspace{9mu}\text{weight}} \right.\text{,}}$$$$\mspace{72mu}{\text{FR}\left( \%/\text{d} \right) = 100 \times \text{total}\mspace{9mu}\text{feed}\mspace{9mu}\text{consumption}/{\qquad\left\lbrack \text{total}\mspace{9mu}\text{days}\mspace{9mu}\text{of}\mspace{9mu}\text{the}\mspace{9mu}\text{experiment} \times \left( \text{fish}\mspace{9mu}\text{final}\mspace{9mu}\text{weight}\mspace{72mu} + \text{fish}\mspace{9mu}\text{initial}\mspace{9mu}\text{weight} \right)/2 \right\rbrack}\text{,}}$$$$\qquad{\text{Total}\mspace{9mu}\text{feed}\mspace{9mu}\text{consumption}\left( \text{g} \right) = \text{total}\mspace{9mu}\text{feed}\mspace{9mu}\text{casted} - \text{total}\mspace{9mu}\text{feed}\mspace{9mu}\text{residue}\text{,}}$$$$\quad{\text{FE} = \text{wet}\mspace{9mu}\text{weight}\mspace{9mu}\text{gaining}\left( \text{g} \right)/\text{total}\mspace{9mu}\text{dry}\mspace{9mu}\text{feed}\mspace{9mu}\text{consumption}\left( \text{g} \right)\text{.}}$$

After final weighing of fish for each tank, seven fish were randomly selected from each tank for measuring body weight (BW) and body length (BL). Intestine growth was assessed by ratio of intestine length to weight (as percent body length to weight). Blood was collected from the caudal vasculature of each fish and equally pooled based on each tank. One part of the blood was added to heparin-containing tubes, stored at 4°C for 1 h, followed by tests for haematological parameters. Another part of the blood was allowed to clot at room temperature for 1 h. The clot was removed and serum was collected by centrifugation (836 × *g*, 10 min, 4°C) and stored at −70°C until use. Equal portion of liver sample from each fish pooled for each tank, and stored at −70°C for biochemical index analysis. The intestines without the mesenteric adipose were weighed, and measured for total length. Dorsal muscles from fish back were dissected and dried at 105°C for analysis of biochemical components.

2.3. Biochemical analysis and nutritional composition {#sec2.3}
-----------------------------------------------------

The total protein and albumin contents in the blood were assessed based on clinical methods ([@bib32]) using the appropriate NJBRI kits (Nanjing, China) according to the manufacturer׳s instructions. Blood hemocrit levels were measured using the capillary tube method. The haemoglobin levels were measured by the haemiglobincyanide (HiCN) method. The erythrocytes and leucocytes were counted using blood-cell counting plates. The tilapia livers were analysed for malondialdehyde levels and activities of superoxide dismutase (SOD) by NJBRI kits (Nanjing, China).

The proximate compositions of the dried muscles were determined. Protein level was assayed by the Kjeldahl method ([@bib4]); fat content was measured via Soxhlet extraction ([@bib20]); and ash weight was measured after burning at 550°C in a muffle furnace.

2.4. Non-specific immunological assays {#sec2.4}
--------------------------------------

The levels of complement proteins C3 and C4 and lysozyme activity in the serum were assayed. The complement proteins C3 and C4 were tittered using an ELISA kit (Shanghai Jianglai Biotechnology Co., Ltd., Shanghai, China). This kit was fully validated for Nile tilapia tissue extracts. Lysozyme activity was determined following the previous method ([@bib26]) based on the lysis of the lysozyme sensitive Gram positive bacterium, *Micrococcus lysodeikticus* (Sigma, St. Louis, MO USA).

2.5. Intestinal *microbial analyses by denaturing gradient gel* {#sec2.5}
---------------------------------------------------------------

Three fish per tank were selected for intestinal microbial analysis according to the method of [@bib39]. The full intestines of the hybrid tilapias were aseptically removed, opened, and gently washed three times with sterile phosphate-buffered saline (PBS, pH 7.2) to remove the contents and non-adhesive bacteria. Then the genomic DNA of intestine and adhesive bacteria was extracted, followed by PCR- (denaturing gradient gel electrophoresis) DGGE analysis. The target sequence (the V3 region of the gene *ssr*) was amplified by PCR using primers 338F (5′-ACTCCTACGGGAGGCAGCAG-3′) and 519R (5′-ATTACCGCGGCTGCTGG -3′). The PCR amplification consisted of an initial denaturing step at 95°C for 5 min, followed by 30 cycles (94°C for 30 s, 56°C for 30 s and 72°C for 30 s), and an additional final extension at 72°C for 10 min. The PCR products were analysed by DGGE with a constant voltage of 60 V at 60°C for about 16 h. Gels were stained with ethidium bromide (5 µg/mL) for 20 min and photographed with UV transillumination. The richness of the detected microorganism was evaluated by the relative intensity of the band. Computer-assisted comparison of DGGE patterns was performed with NTsys v2.10. The representative bands were excised, reamplified with primers 338F and 519R, and sequenced at Beijing Calculation Centre (Beijing, China). The sequences of the partial 16S rRNA gene were input as the query sequence in BLASTn and the top hit species was recorded.

2.6. Data analysis {#sec2.6}
------------------

Data were subjected to one-way ANOVA to test the effects of dietary nucleotide supplementation. Duncan׳s multiple range test was used to compare the means among the different groups. Broken-line or polynomial regression analysis was used to determine the optimum doses for growth and feed efficiency. Differences in the relative abundance of phylotypes were analysed by Student׳s *t*-test. Differences with a *P* value lower than 0.05 were considered as significant. All the statistical analysis was conducted on SPSS 17.0.

3. Results {#sec3}
==========

3.1. Growth performance and intestine growth {#sec3.1}
--------------------------------------------

The initial tilapia weights in all treatments were similar. Nucleotide supplementation did not affect the feeding intake, indicating no effect of nucleotides on palatability ([Table 2](#tbl2){ref-type="table"}). Significantly improved WG was recorded in the 0.60% group compared with the control (*P* \< 0.05). In 0.30 and 1.20% groups, the WG was marginally increased but was not significantly different from the WG of control group. Significantly higher FE was observed in 0.60 and 1.20% supplement groups compared with the control, with the highest efficiency recorded in 0.60% group. Based on the broken line and polynominal regression analysis, the optimum doses corresponding to the highest WG and FE were calculated as 0.63 and 0.81%, respectively ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Regression analysis of dose-response effect of nucleotides supplementation on weight gain (A) and feed efficiency (B) of hybrid tilapia. Broken-line and polynomial models were fitted for the two cases, respectively. The vertical line indicates doses corresponding to the optimal performance. WG = weight gain; FE = feed efficiency.Table 2Growth and developmental performance of hybrid tilapia after feeding nucleotide supplemented diets for eight weeks.TreatmentIBW, gWG, %FRFEIL:BLIW:BWControl7.85 ± 0.23^a^265.46 ± 9.50^a^2.95 ± 0.04^a^0.69 ± 0.01^ab^4.34 ± 0.09^a^1.52 ± 0.13^a^0.15% nucleotides8.07 ± 0.12^a^254.36 ± 19.60^a^2.87 ± 0.07^a^0.67 ± 0.02^a^4.81 ± 0.17^ab^1.58 ± 0.21^a^0.30% nucleotides8.03 ± 0.15^a^286.76 ± 13.01^ab^2.89 ± 0.11^a^0.73 ± 0.02^bc^4.87 ± 0.12^b^1.61 ± 0.21^a^0.60% nucleotides8.03 ± 0.12^a^332.62 ± 14.00^b^2.94 ± 0.06^a^0.76 ± 0.01^c^4.87 ± 0.08^b^1.73 ± 0.12^a^1.20% nucleotides8.13 ± 0.09^a^295.36 ± 4.65^ab^2.91 ± 0.07^a^0.74 ± 0.01^c^4.56 ± 0.14^ab^1.62 ± 0.13^a^[^5][^6]

No significant changes were observed between treatment groups and the control in the content of dry matter, protein, lipid and ash in fish muscle, suggesting a negligible effect of nucleotide supplementation on the storage of such components in muscle ([Table 3](#tbl3){ref-type="table"}).Table 3The chemical compositions of fish flesh (% as wet) after feeding nucleotide supplemented diets for eight weeks.TreatmentDry matter, %Protein, % as wetLipid, % as wetAsh, % as wetControl24.97 ± 0.89^a^15.93 ± 0.58^a^3.87 ± 0.09^ab^2.21 ± 0.06^a^0.15% nucleotides24.36 ± 0.6^a^15.20 ± 1.46^a^4.18 ± 0.02^a^2.09 ± 0.20^a^0.30% nucleotides24.43 ± 0.5^a^15.23 ± 0.21^a^3.53 ± 0.16^b^1.96 ± 0.06^a^0.60% nucleotides25.17 ± 0.68^a^16.51 ± 0.82^a^3.73 ± 0.19^ab^1.90 ± 0.05^a^1.20% nucleotides25.82 ± 0.66^a^16.24 ± 0.70^a^3.99 ± 0.20^ab^2.03 ± 0.10^a^[^7]

Fish, which were fed diets with 0.30 and 0.60% nucleotides, had increased intestine length (*P* \< 0.05). However, the intestine weight was not significantly different between treatment groups and the control, although the nucleotide supplementation groups showed numerically higher weight ([Table 2](#tbl2){ref-type="table"}).

3.2. Haematological parameters {#sec3.2}
------------------------------

Dietary nucleotide supplementation had no significant influence on hemocrit. However, the haemoglobin content was significantly improved in 0.30 and 0.60% groups compared with the control, and the 0.60% group exhibiting the highest content. Serum total protein and globulin content were not influenced by nucleotide supplementation. Albumin content decreased significantly in the 0.15, 0.30 and 0.60% groups compared with the control. Significantly reduced albumin-to-globulin ratio (A:G) was observed in the 0.60% group ([Table 4](#tbl4){ref-type="table"}).Table 4Effect of dietary nucleotides on haematological parameters.TreatmentTotal protein, g/LAlbumin, g/LGlobulin, g/LA:G ratioControl46.05 ± 1.47^b^13.37 ± 0.53^b^32.69 ± 1.35^a^0.41 ± 0.02^a^0.15% nucleotides42.52 ± 2.4^b^11.28 ± 0.27^a^31.24 ± 2.22^a^0.36 ± 0.02^ab^0.30% nucleotides43.89 ± 1.08^b^11.15 ± 0.29^a^32.73 ± 0.90^a^0.34 ± 0.01^ab^0.60% nucleotides45.82 ± 1.87^b^11.05 ± 0.49^a^34.78 ± 1.40^a^0.32 ± 0.01^b^1.20% nucleotides43.64 ± 1.45^b^12.24 ± 0.56^ab^31.40 ± 1.62^a^0.39 ± 0.03^a^[^8][^9]

3.3. Anti-oxidant status and non-specific immunity {#sec3.3}
--------------------------------------------------

Super oxide dismutase activity in the liver was significantly improved in the 0.15, 0.60 and 1.20% nucleotide groups than in the control, with the highest SOD activity recorded in the 0.60% group. Accordingly, the MDA concentration in the liver decreased significantly in the 0.6 and 1.20% groups compared to the control ([Table 5](#tbl5){ref-type="table"}). The lysozyme activity was significantly increased in the 0.15 and 0.30% groups compared with the control (*P* \< 0.05). Both C3 and C4 concentrations were not significantly influenced by dietary nucleotides ([Table 5](#tbl5){ref-type="table"}).Table 5Effects of dietary nucleotides on anti-oxidant activity in the liver and non-specific immunological parameters in serum.TreatmentSOD, U/mgprotMDA, nmol/mgprotLYZ, U/mLC3, g/LC4, g/LControl387.06 ± 9.71^a^2.03 ± 0.11^a^1400.00 ± 43.26^a^0.49 ± 0.03^ab^0.45 ± 0.04^a^0.15% nucleotides478.59 ± 19.43^b^2.08 ± 0.17^a^1620.05 ± 60.41^b^0.53 ± 0.03^ab^0.45 ± 0.06^a^0.30% nucleotides434.76 ± 32.18^ab^1.87 ± 0.09^b^1671.43 ± 44.38^b^0.48 ± 0.09^ab^0.48 ± 0.01^a^0.60% nucleotides488.58 ± 27.91^b^1.72 ± 0.12^c^1557.14 ± 32.72^ab^0.60 ± 0.02^a^0.45 ± 0.05^a^1.20% nucleotides467.89 ± 12.37^b^1.73 ± 0.13^c^1541.27 ± 72.86^ab^0.44 ± 0.05^b^0.40 ± 0.01^a^[^10][^11]

3.4. Effects of nucleotide supplements on adhesive intestinal microbiota {#sec3.4}
------------------------------------------------------------------------

The PCR-DGGE fingerprints of the 16S rRNA gene (V3 region) from the adhesive intestinal microbiota are shown in [Fig. 2](#fig2){ref-type="fig"}. Band excision and sequencing produced sequences for 14 representative bands. BLASTn analysis of the band sequences revealed species belonging to *Firmicutes*, *Enterobacteriaceae*, and *Bacteroides* ([Table 6](#tbl6){ref-type="table"}). *Firmicutes* represented the largest group of bacteria, accounting for 9 out of the 14 sequenced bands and around 70% in relative abundance. The microbial composition profile of the 0.60% nucleotide group was compared with that of the control in detail, for its optimum effect on growth and other parameters. Overall, nucleotide supplementation did not exert significant influence on the intestinal microbiota, as indicated by cluster analysis, where *Cs* over 0.75 was observed for all the intestinal samples ([Fig. 3](#fig3){ref-type="fig"}). Relative abundance of species related to *Clostridium acidurici* (Band 4) and *Plesiomonas shigelloides* (Band 7) was significantly reduced in the 0.6% group compared with the control. Richness of a species related to *Lachnospiraceae* (Band 12) decreased to zero in the 0.6% group compared with the control, while a *Plesiomonas* species (Band 6) was significantly enriched in the 0.60% supplemented group, as compared to zero abundance in the control ([Table 6](#tbl6){ref-type="table"}). Notably, species closely related to *Anaerostipes hadrus* (Band 11) and *Faecalibacterium prausnitzii* (Band 10), which are both predominant butyrate-producing bacteria in human colon ([@bib1], [@bib19]), were revealed in both the control and nucleotide supplement groups. On top of that, another two phylotypes (Band 1 & Band 12) were considered as putative butyrate-producing bacteria, as they were identified as *Lachnospiraceae*, a family of bacteria with many of its members associated with butyrate production ([@bib21]). The cumulative abundance of Band 10 and Band 11 was 7.41 and 5.36%, in the control and 0.6% groups, respectively, while the cumulative abundance of Bands 1, 10, 11 and 12, representing all the putative butyrate-producing bacteria, were 19.09 and 11.77%, in the control and the 0.60% group, respectively ([Table 6](#tbl6){ref-type="table"}). Notably, in both cases, the cumulative abundance of putative butyrate-producing bacteria was reduced in the nucleotide supplementation group compared with the control (*P* = 0.08 and *P* \< 0.0001, for the two bands and four bands, respectively) ([Table 6](#tbl6){ref-type="table"}).Fig. 2The PCR-DGGE fingerprints of the16S rRNA gene (V3 region) from the adhesive intestinal microbiota of hybrid tilapia after the eight weeks of feeding. Three fish were randomly selected to isolate gut content for gut bacteria detection by PCR-DGGE (*n* = 3). NT = nucleotides.Fig. 3Cluster analysis of the intestinal microbiota of hybrid tilapia in the control and 0.6% nucleotides inclusion group based on 16S rRNA gene V3 denaturing gradient gel electrophoresis (DGGE) fingerprints. C1, C2, C3 = triplicates of control group; 0.6%-1, 0.6%-2, 0.6%-3 = triplicates of 0.6% group.Table 6Closest relatives and relative abundance of bands from 16S rRNA gene V3 PCR-DGGE fingerprint of adhesive microbiota for the control and 0.6% groups.PhylumBand No.Closest relative (BLAST search)Identity, %Relative abundance[1](#tbl6fn1){ref-type="table-fn"}, %Control0.60% nucleotidesFirmicutes1Lachnospiraceae bacterium (GU723317.1)996.4 ± 1.06.0.4 ± 0.53*Streptococcus pleomorphus* (NR_044660.1)10018.1 ± 0.721.1 ± 2.04^⁎^*Clostridium acidurici* (HE582772.1)989.9 ± 0.37.9 ± 0.68*Clostridium beijerinckii* (AB600543.1)1003.5 ± 0.81.4 ± 0.79*Robinsoniella peoriensis* (JN642224.1)983.3 ± 0.52.6 ± 0.310*Faecalibacterium prausnitzii* (HQ457030.1)1004.1 ± 0.44.4 ± 0.611*Anaerostipes hadrus* (NR_104799.1)1003.3 ± 0.31.0 ± 1.012^⁎⁎⁎^Lachnospiraceae bacterium (EU728751.1)1005.3 ± 0.5014*Streptococcus* sp. (FJ611790.1)10024.0 ± 4.028.1 ± 0.710 + 11[2](#tbl6fn2){ref-type="table-fn"}----7.4 ± 0.25.4 ± 0.91 + 10+11 + 12^⁎⁎⁎^[2](#tbl6fn2){ref-type="table-fn"}----19.1 ± 0.511.8 ± 0.4Proteobacteria5*Escherichia coli* (KC138767.1)1001.4 ± 1.43.9 ± 0.26^⁎⁎⁎^*Plesiomonas* sp. (FJ405284.1)10003.6 ± 1.07^⁎^*Plesiomonas shigelloides* (JQ582978.1)996.3 ± 0.63.9 ± 0.513*Plesiomonas* sp. (AB192384.1)1007.4 ± 1.08.0 ± 0.6Bacteroidetes2*Bacteroides propionicifaciens* (AB264624.2)1007.2 ± 0.27.7 ± 0.5[^12][^13][^14]

4. Discussion {#sec4}
=============

One of main contributions was to uncover the optimal dosage of nucleotide supplement for the aquaculture of juvenile hybrid tilapia. Combined with growth performance, feed efficiency, immunity and intestine growth, 0.60% addition of nucleotide in diets was optimal. Dose-response effects of dietary nucleotides inclusion were investigated in a few studies ([@bib13], [@bib17], [@bib29], [@bib35]) and the large variation of optimal doses in these studies may be due to differences among species. Another important confounder may come from the difference in actual levels of nucleotides in the commercial products. Moreover, some ingredients in the basal diet, such as fish meal, are high in nucleotides, and the reported optimal doses of nucleotides actually reflect levels that was additional to nucleotides already present in the basal diet ([@bib13]). The commercial nucleotide products extracted from yeast commonly contain impure components such as trace element and polysaccharides ([@bib17]). The compromised performance of fish fed the nucleotide at a level higher than 0.60% confirmed nucleotides as the active component for the observed improvements, as the effects of other potential ingredients would not likely peak at such a low inclusion dose, considering their low concentrations in the yeast nucleotides product.

Dietary nucleotides supplementation has been reported to improve intestinal microstructure morphology in terms of increased fold height, enterocyte height and microvilli length in different enteric sections of fish ([@bib5], [@bib10]). The resultant increase in the mucosal surface area was suggested as a contributing factor to the improved growth of fish ([@bib5]). In our study, longer intestine length were observed in 0.30 and 0.60% nucleotide groups, indicating improvement of intestine growth by dietary nucleotide supplementation. Notably, the intestine length also peaked at 0.6% nucleotide supplementation, with reduced length observed at the 1.2% group. This pattern was consistent with that for the growth performance and feed utilization, implying that the improved growth of the intestine may contribute to nutrient digestion and absorption and therefore the growth of fish.

Tissue MDA content is widely used as biomarker for oxidative damage of lipids, which may result from generation of excess reactive oxygen species (ROS) ([@bib37]). The ROS can be removed by antioxidant enzymes, with SOD as a key component in this system. In this study, the MDA content and SOD activity in the liver tissue were tested. Significantly improved SOD activity and lower MDA were observed in the 0.60 and 1.20% groups compared with the control, indicating that nucleotides supplementation may enhance the anti-oxidant status of the liver in hybrid tilapia. Further research is warranted to investigate if similar effect exists in other tissues.

Serum complement and lysozyme activity are important components of the humoural innate immune system, protecting fish from potentially invasive organisms ([@bib29]). In the present study, serum lysozyme activity was improved in the 0.15 and 0.30% groups, indicating a stimulating effect of nucleotides on the innate immune response of hybrid tilapia. However, the complement activity, as assayed by C3 and C4 levels which plays a central role in the complement system and contributes to innate immunity, was not influenced, which doesn׳t agree with the positive effects reported in other species ([@bib27], [@bib29]). Marginally higher levels of serum globulin and significantly lower A:G ratio were observed in the 0.60% group compared with the control, indicating the presence of more globulin. A higher concentration of globulin and lower A:G ratio have been associated with enhanced antibody response in fish ([@bib11]). Therefore, dietary nucleotides supplementation has the potential to lead to enhanced antibody response of tilapia under vaccination or challenges. Nevertheless, further research is warranted to investigate whether the improved immunity may translate to enhanced disease resistance of tilapia, as reported in many other aquatic species ([@bib6], [@bib16], [@bib27]).

Only the microbial pattern of the 0.60% group was compared with the control in detail, due to its optimal effect on growth and other parameters. The nucleotide supplementation exerted a moderate influence on the intestinal microbiota of tilapia, with only four low-abundance phylotypes significantly affected in the 0.60% group compared with the control. In humans, a similar scale of influence on gut microbiota was observed with nucleotide supplementation, which was associated with considerable differences in microbiota balance and function ([@bib28]). Therefore, the change of the intestinal microbiota of hybrid tilapia induced by nucleotide supplementation should not be considered negligible.

Species of bacteria associated with butyrate production were found in the microbiota of tilapia, including *Anaerostipes hadrus*, *Faecalibacterium prausnitzii*, and species belonging to *Lachnospiraceae*. *Anaerostipes hadrus* represents more than 2% of the total microbiota in the healthy colon of humans and may produce butyrate from lactic acid at mildly acidic conditions ([@bib1]). In both cases, the cumulative abundance of putative butyrate-producing species decreased in the nucleotide supplementation group. Although the information needs to be confirmed in fish, butyrate is the primary energy source for the epithelial enterocytes ([@bib19]). The decreased abundance of butyrate-producing bacteria in the intestinal microbiota of fish might be due to a competing or substituting effect between butyrate and nucleotides as energy-providers for the enterocytes of fish, as nucleotides may also provide energy for cells, besides acting as base units for nucleic acid synthesis and a series of other physiological and biochemical functions ([@bib31]). It is also known that intestinal mucosal tissues have limited capacity for the *de novo* synthesis of nucleotides and depend on supply by the salvage pathway ([@bib24], [@bib36]). In this regard, dietary nucleotides may save energy for the intestinal mucosal tissues, as the salvage pathway requires high energy ([@bib2], [@bib12]). The consequent decreased demand for energy of the intestinal mucosal tissues might also contribute to the reduction in the abundance of butyrate-producers, as butyrate is putative energy source for the enterocytes. Alternatively, the observed change in the abundance of butyrate-producing bacteria may be a direct inhibition effect of nucleotides. In human study, the improved richness of bifidobacteria was attributed to a direct nutritional or prebiotic effect of nucleotides ([@bib28]). Due to the limited knowledge about dietary supplemented nucleotides in fish, especially on their metabolism and influence on various physiological processes, it is hard to determine the mechanisms of the effect of dietary nucleotides on intestinal microbiota and in particular the potential interaction of nucleotides supplementation with butyrate production, metabolism and associated butyrate producing bacteria. Further investigations on this topic are meaningful, especially considering that butyrate has been used as functional dietary supplements in fish feed ([@bib18]).

5. Conclusion {#sec5}
=============

Dietary nucleotide supplementation may improve the growth, feed utilization, intestinal growth, anti-oxidant status and non-specific immune response of hybrid tilapia. Regression analysis results for weight gain and feed efficiency, as well as the dose-response results of other parameters, suggest a dietary level between 0.6 and 0.8% to give optimal performance of juvenile hybrid tilapia. Nucleotide supplementation exerted moderate influence on the intestinal microbiota of tilapia, and the cumulative abundance of putative butyrate-producing species in the intestinal microbiota was reduced by nucleotide supplementation, suggesting interaction between dietary nucleotides and butyrate production, which deserves further investigation.
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[^1]: These authors contributed equally to this work.

[^2]: Ingredient source: white fishmeal (Siberia, Russia), fly maggot meal (Shangdong, China), soybean meal (Jiangsu, China), wheat (Henan, China), vitamin C (Hebei, China), choline chloride (Hebei, China), a-starch (Jiangsu, China), zeolite powder (Hebei, China).

[^3]: Contains (per kg premix): thiamin, 20 mg; riboflavin 20 mg; pyridoxine 20 mg; cyanocobalamine 0.020 mg; phylloquinone 10 mg; folic acid 5 mg; calcium patotheniate 50 mg; inositol 100 mg; niacin 100 mg; tocopherol 50 mg; biotin 0.1 mg; retinol 55,000 IU; cholecalciferol 10,000 IU; carrier up to 1 kg.

[^4]: Contains (as g/kg premix): NaCl, 1 g; MgSO~4~·7H~2~O, 15 g; KH~2~PO~4~, 32 g; FeC~6~H~5~O~7~·5H~2~O, 0.25 g; C~6~H~10~CaO~6~·5H~2~O, 3.5 g; ZnSO~4~·7H~2~O, 0.353 g; MnSO~4~·4H~2~O, 0.162 g; CuSO~4~·5H~2~O, 0.031 g; CoCl~2~·6H~2~O, 0.001 g; KIO~3~, 0.003 g; carrier up to 1 kg.

[^5]: ^a,\ b,\ c^ Data are means of triplicate, and presented as mean ± SEM Means in each column with a common superscript are not significantly different (*P* \> 0.05.)

[^6]:  IBW = initial body weight; WG = weight gain; FR = feeding rate; FE = feed efficiency; IL:BL = ratio of intestine length to body length; IW:BW = the ratio of intestine weight to body weight.

[^7]: ^a,\ b^ Data are means of triplicate, and presented as means ± SEM. Means in each column with a common superscript are not significantly different (*P* \> 0.05).

[^8]: ^a,\ b^ Data are means of triplicate, and presented as means ± SEM. Means in each column with a common superscript are not significantly different (*P* \> 0.05).

[^9]:  A:G = ratio of albumin to globulin.

[^10]: ^a,\ b,\ c^ Data are means of triplicate, and presented as means ± SEM. Means in each column with a common superscript are not significantly different (*P* \> 0.05).

[^11]:  SOD = super oxide dismutase; MDA = malondialdehyde; LYZ = lysozyme; C3 and C4 are complement proteins C3 and C4.

[^12]: ^⁎^ and ^⁎⁎⁎^ represent significant differences *P* \< 0.05 and *P* \< 0.001, respectively, in relative abundance of the band(s) between the control and 0.60% groups.

[^13]: Relative abundance data are means of triplicate and presented as means ± SEM, *n* = 3.

[^14]: Cumulative relative abundance of putative butyrate-producing species in the adhesive intestinal microbiota.
